Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (5.558)

91

Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol : a multicentre randomised controlled trial

enthalten in: Anaesthesia | 2024

von Fechner, J. | El-Boghdadly, K. | Spahn, D. | +15

92

A post hoc analysis of previously untreated patients with severe hemophilia A who developed inhibitors in the PUPs A-LONG trial

enthalten in: Blood advances | 2024

von Carcao, M. | Schiavulli, M. | Kulkarni, R. | +5

93

Guselkumab provides durable improvement across psoriatic arthritis disease domains : post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study

enthalten in: RMD open | 2024

von Coates, L. | Gossec, L. | Zimmermann, M. | +8

94

Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial

enthalten in: Journal for immunotherapy of cancer | 2024

von Ten Ham, R. | Rohaan, M. | Jedema, I. | +13

95

Long-term treatment with lasmiditan in patients with migraine : post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial

enthalten in: The journal of headache and pain | 2024

von Komori, M. | Ozeki, A. | Tanji, Y. | +6

96

Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2024

von Fonteyne, V. | Berghen, C. | Van Praet, C. | +8

97

Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia : a phase 3, double-blind, randomised controlled trial

enthalten in: Lancet (London, England) | 2024

von Ochoge, M. | Futa, A. | Umesi, A. | +18

98

Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR) : 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial

enthalten in: Lancet (London, England) | 2024

von Lanzetta, P. | Korobelnik, J. | Heier, J. | +22

99

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON) : 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

enthalten in: Lancet (London, England) | 2024

von Brown, D. | Boyer, D. | Do, D. | +124

100

Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE) : a randomised, placebo-controlled, phase 3b trial

enthalten in: The Lancet. Neurology | 2024

von Tassorelli, C. | Nagy, K. | Pozo-Rosich, P. | +7